90 more pills become cheaper / 3200 pens have not changed in price

Mohammad Hashemi, spokesman for the Food and Drug Administration, said in an interview with a Fars News Agency health reporter: “About 90 items of medicine were not covered by insurance after the price was corrected due to the use of the Nimai currency, which was ordered by the president to insurance organizations.” It has been agreed that the price of these 90 items of medicine will be returned so that there will be no difference in people’s out-of-pocket payments. The program and budget organization is also set to act from the place of saving and targeted subsidies to provide its resources.

He said: “It should be noted that in this case, the main price of drugs for the people will not change, but the excess costs will be paid by insurance and eventually the patients’ payment will be returned to the previous one.”

Hashemi added: there is no expensive drug store in the official distribution network; Because the price of the drug is monitored with a strong regulatory system and different supply models, whether with half or preferential currency, are approved by the commission, and the final price is recorded in the Titek system.

He said: out of 3580 items of medicine in the thirteenth government, the pricing of 380 items is done by the commission and the price of 3200 items of medicine has not changed.

A spokesman for the Food and Drug Administration stated: “The basis of insurance support will be generic and domestically produced drugs.” Also, out of the total pharmaceutical pharmacopoeia of the country, 2500 items are covered by insurance, and we plan to add another 250 important items to this list.

He emphasized: it should be mentioned that the Minister of Health has emphasized to the universities of medical sciences, while carefully and regularly controlling the performance of private and hospital pharmacies and drug distribution companies and medical equipment and informing the covered drugs in order to prevent the spread of deficiencies. False drugs and increasing the confidence of consumers and patients, especially special and incurable patients, in the manner of providing and quality of pharmacy services in relation to continuous field visits in a special way and in the form of regulatory maneuvers.

Hashemi said: “Universities of medical sciences are also obliged to monitor prices, observe legally approved tariffs and distribution and supply profits, in case of any violations of overselling and increase in prices of medicine and medical equipment, underselling and hoarding and unauthorized storage in accordance with the law.” And the regulations related to medical and pharmaceutical affairs, the law of government penalties in health and medical affairs and the law of combating smuggling of goods and currency and other current regulations have the necessary legal action against the violators and report these measures to the Food and Drug Administration on a monthly basis. Send.

End of message / 25